EP Patent

EP1642607A1 — Dose display mechanism for a drug delivery device

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2006-04-05 · 20y expired

What this patent protects

This invention relates to a dose display mechanism for a drug delivery device (1) that allows the user to select multiple doses of an injectable drug and for the dispensing of the set dosage of the drug and applying said drug to a patient, preferably by injection.

USPTO Abstract

This invention relates to a dose display mechanism for a drug delivery device (1) that allows the user to select multiple doses of an injectable drug and for the dispensing of the set dosage of the drug and applying said drug to a patient, preferably by injection.

Drugs covered by this patent

testosterone-enanthate (TESTOSTERONE ENANTHATE)

Patent Metadata

Patent number: EP1642607A1
Jurisdiction: EP
Classification: —
Expires: 2006-04-05
Drug substance claim: No
Drug product claim: No
Assignee: Sanofi Aventis Deutschland GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.